1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Optic Nerve Injuries: new trials by email Literature Review of Optic Nerve Injuries trials Research Report on Optic Nerve Injuries
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Intravenous Methylprednisolone and Intravenous Erythropoietin in Toxic Optic Neuropathies: Randomized Clinical Trial. Recombinant human erythropoietin 4,000 UI and 2,000 UI, Methylprednisolone succinate 500 mg - Toxic Optic Neuropathy, Treatment | Phase 2 / Phase 3 | Unknown | Asociación para Evitar la Ceguera en México | 18 | 2022-04-05 | 2023-02-28 |
Chemically-Induced Disorders (1) · Cranial Nerve Diseases (1) · Cranial Nerve Injuries (1) · Craniocerebral Trauma (1) · Drug-Related Side Effects and Adverse Reactions (1) · Eye Diseases (1) · Nervous System Diseases (1) · Optic Nerve Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Radiation Injuries (1) · Trauma, Nervous System (1) · Wounds and Injuries (1)
Control Groups (1) · Methylprednisolone Hemisuccinate (1)
Asociación para Evitar la Ceguera en México (1)
Mexico (1)